8-Country IMP Clinical Trial Logistics Success

The Challenge: Complex Regulatory Clearance & Cold-Chain Integrity

A major global biotech firm based in Switzerland initiated a Phase III oncology clinical trial requiring patient enrollment across 8 countries in East and Southern Africa, including Kenya, Uganda, Tanzania, Rwanda, and South Africa.

The Investigational Medicinal Product (IMP) and associated diagnostic kits were highly sensitive: they required constant temperature controls of -20°C and 2°C to 8°C. Any temperature excursion would invalidate the IMP kits, causing massive financial losses and patient enrollment delays. Additionally, importing clinical trial supplies into these markets required distinct national regulatory permits (e.g. PPB in Kenya, NDA in Uganda, SAHPRA in South Africa) and local legal entities to act as importer.

The Solution: Centralized Import-of-Record (IOR) & GDP Distribution

PharmaMED was contracted as the sole logistics and regulatory partner for the region. We structured an end-to-end clinical trial supply chain solution:

• ✓ Legal IOR Representation: PharmaMED acted as the registered local importer in Kenya, South Africa, and Ghana, securing all necessary regulatory import approvals and taking legal responsibility for compliance.
• ✓ Fast-Track Customs Clearing: Utilizing our secured clearing agency status, we coordinated pre-clearance documentation before shipments departed Europe, reducing airport storage time to less than 4 hours.
• ✓ Cold Chain Integrity: We managed the storage at our GDP-compliant facility using continuously logged cold rooms and mapped ambient zones, and packed the kits in validated passive shippers for clinical site dispatch.

The Results

Over the 18-month trial period, PharmaMED successfully imported, cleared, and delivered over 1,200 clinical kits. We maintained a 100% success rate with zero temperature excursions during customs delays or internal transit.

By leveraging our localized knowledge, the manufacturer successfully avoided costly port storage, compliance queries, and regulatory fines, completing the trial within the original sponsor timeline.